Fattori di rischio per NMOSD
Saperne di più
AQP4, acquaporina-4; HLA, antigene leucocitario umano; IgG, immunoglobulina G; IL17A, interleuchina 17A; NMOSD, disturbo dello spettro della neuromielite ottica.
Jarius S, et al. Neuromyelitis optica. Nat Rev Dis Primers. 2020;6(1):85. Wingerchuk DM, Lucchinetti CF. Neuromyelitis optica spectrum disorder. N Engl J Med. 2022;387(7):631–639.  Weinshenker BG, Wingerchuk DM. Neuromyelitis spectrum disorders. Mayo Clin Proc. 2017;92(4):663–679. 
 Neuromyelitis Optica Spectrum Disorder. National Organization for Rare Disorders (NORD). Available from: https://rarediseases.org/rare–diseases/neuromyelitis–optica/. Last accessed: April 2023.